| Basics |
Krystal Biotech, Inc.
Krystal Biotech Inc is a biopharmaceutical company. It uses gene therapy treatments for patients suffering from rare debilitating disorders.
|
| IPO Date: |
September 20, 2017 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$5.52B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.83 | 2.62%
|
| Avg Daily Range (30 D): |
$3.24 | 1.89%
|
| Avg Daily Range (90 D): |
$2.88 | 1.87%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.16M |
| Avg Daily Volume (30 D): |
.25M |
| Avg Daily Volume (90 D): |
.26M |
| Trade Size |
| Avg Trade Size (Sh.): |
43 |
| Avg Trade Size (Sh.) (30 D): |
32 |
| Avg Trade Size (Sh.) (90 D): |
33 |
| Institutional Trades |
| Total Inst.Trades: |
2,120 |
| Avg Inst. Trade: |
$3.87M |
| Avg Inst. Trade (30 D): |
$5.57M |
| Avg Inst. Trade (90 D): |
$5.48M |
| Avg Inst. Trade Volume: |
.03M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$4.88M |
| Avg Closing Trade (30 D): |
$7.79M |
| Avg Closing Trade (90 D): |
$7.55M |
| Avg Closing Volume: |
41.01K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
|
$1.33
|
$1.24
|
|
Diluted EPS
|
|
$1.29
|
$1.2
|
|
Revenue
|
$
|
$ 96.04M
|
$ 88.18M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$
|
$ 38.33M
|
$ 35.73M
|
|
Operating Income / Loss
|
$
|
$ 39.31M
|
$ 36.18M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$
|
$ 45.06M
|
$ -36.1M
|
|
PE Ratio
|
|
|
|
|
|
|
